PRESS RELEASE published on 02/14/2025 at 19:00, 1 year 7 months ago Oxurion renforce son Conseil d'Administration avec l'arrivée de Nelly Souleymane Oxurion NV annonce des changements au sein de son Conseil d'Administration, renforçant la diversité et l'expertise stratégique. L'arrivée de Nelly Souleymane vise à améliorer la communication et la gouvernance Gouvernance Conseil D'administration Communication Oxurion NV Nelly Souleymane
BRIEF published on 01/20/2025 at 18:05, 1 year 8 months ago Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Transparency Notification Share Acquisition Atlas Special Opportunities Oxurion Retinal Disease Therapies
BRIEF published on 01/20/2025 at 18:05, 1 year 8 months ago Oxurion reçoit une notification de transparence de la part d'Atlas Special Opportunities LLC Acquisition D'actions Oxurion Opportunités Spéciales Atlas Avis De Transparence Thérapies Pour Les Maladies De La Rétine
PRESS RELEASE published on 01/20/2025 at 18:00, 1 year 8 months ago Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Oxurion NV receives transparency notification regarding shares ownership from Atlas Special Opportunities, LLC, crossing the 20% threshold. Company engaged in developing ophthalmic therapies Transparency Notification Ophthalmic Therapies Oxurion NV Shares Ownership Belgian Transparency Legislation
PRESS RELEASE published on 01/20/2025 at 18:00, 1 year 8 months ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC over aankoop aandelen, voldoet aan Belgische transparantiewetgeving. Oogheelkundig bedrijf gevestigd in Leuven, België Transparantiekennisgeving Oxurion NV Biofarmaceutisch Netvliesaandoeningen Belgische Transparantiewetgeving
BRIEF published on 01/14/2025 at 18:05, 1 year 8 months ago Oxurion reçoit une mise à jour de transparence d'Atlas Special Opportunities LLC Actions Atlas Transparence Biopharmaceutique Oxurion
BRIEF published on 01/14/2025 at 18:05, 1 year 8 months ago Oxurion Receives Transparency Update from Atlas Special Opportunities LLC Actions Transparency Atlas Biopharmaceutical Oxurion
PRESS RELEASE published on 01/14/2025 at 18:00, 1 year 8 months ago Oxurion ontvangt aangepaste transparantiekennisgeving van Atlas Special Opportunities LLC Oxurion NV ontvangt aangepaste transparantiekennisgeving van Atlas Special Opportunities LLC wegens verkoop van aandelen. Leuven biofarmaceutisch bedrijf actief in oftalmologische therapieën Transparantiekennisgeving Oxurion NV Biofarmaceutisch Oftalmologische Therapieën België
PRESS RELEASE published on 01/14/2025 at 18:00, 1 year 8 months ago Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities LLC Oxurion NV announces receiving an amended transparency notification regarding share ownership by Atlas Special Opportunities, LLC, crossing under the 3% threshold Transparency Notification Share Ownership Atlas Special Opportunities LLC Oxurion NV Retinal Disease
BRIEF published on 01/13/2025 at 18:05, 1 year 8 months ago Oxurion Updates Voting Rights Following Convertible Bond Conversion Voting Rights Convertible Bonds Capital Increase Market Opportunities Oxurion
Published on 09/26/2026 at 01:00, 5 hours 48 minutes ago Guanajuato Silver Renews Base Shelf Prospectus
Published on 09/26/2026 at 01:00, 5 hours 48 minutes ago Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 8 hours 33 minutes ago Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 13 hours 18 minutes ago Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 15 hours 48 minutes ago HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/26/2026 at 00:01, 6 hours 47 minutes ago Photon Energy N.V. Sells 7.6 MWp of PV Operational Assets in Slovakia
Published on 09/25/2026 at 18:30, 12 hours 18 minutes ago 029 Group SE: Publication of Half-Year Report 2026
Published on 09/25/2026 at 18:00, 12 hours 48 minutes ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.08.26
Published on 09/25/2026 at 17:30, 13 hours 18 minutes ago GEVELOT S.A.: Weekly declaration of share buybacks – 09/25/2026 (French only)
Published on 09/25/2026 at 17:45, 13 hours 3 minutes ago COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 13 hours 8 minutes ago Availability of the 2026 half-year financial report
Published on 09/25/2026 at 17:40, 13 hours 8 minutes ago Mise à disposition du rapport financier semestriel 2026
